CoAprovel

Medicinal product

(Invented) name

CoAprovel

Active substance (s)

Irbesartanas/Hidrochlorotiazidas

Strength

300 mg/12,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA04, Irbesartan and diuretics

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

1998-10-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

tablet	1 vnt.
Irbesartanas	300 mg
Hidrochlorotiazidas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
324	6279	1006279	lizdinė plokštelė	N28		Receptinis	EU/1/98/086/004	Netiekiama	-	-	No	-	-
25652	28252	1028252	lizdinė plokštelė	N56		Receptinis	EU/1/98/086/005	Netiekiama	-	-	No	-	-
25653	28253	1028253	lizdinė plokštelė	N98		Receptinis	EU/1/98/086/006	Netiekiama	-	-	No	-	-
25654	28254	1028254	lizdinė plokštelė	N14		Receptinis	EU/1/98/086/008	Netiekiama	-	-	No	-	-
25655	28255	1028255	dalomoji lizdinė plokštelė	N56x1		Receptinis	EU/1/98/086/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
1998-10-15	Registruotas